Major surface glycoprotein (MSG)

The Major surface glycoprotein (MSG) is the most abundant surface protein of the opportunistic fungus Pneumocystis jirovecii, the causative agent of Pneumocystis pneumonia (PCP) (Stringer, 2007). It serves as a primary adhesin, mediating the attachment of the fungus to host alveolar type I pneumocytes and extracellular matrix proteins such as fibronectin and vitronectin (Kutty et al., 2013). MSG is encoded by a large family of approximately 80-100 genes, which allows the pathogen to undergo frequent antigenic variation to evade host immune surveillance (UniProt, 2024). This genetic diversity presents a significant challenge for vaccine development but also makes MSG a valuable biomarker for the diagnosis of PCP through the detection of specific antibodies or DNA sequences in clinical specimens (PubMed, 2021). While current clinical therapies like trimethoprim-sulfamethoxazole target metabolic pathways, MSG is a primary focus for the development of passive immunization strategies and prophylactic vaccines aimed at preventing infection in immunocompromised individuals (Gigliotti & Wright, 2012).

Other names

Glycoprotein AgpASurface glycoproteinMSG complexMajor surface antigen

Blockade of fungal attachment to host alveolar cells and induction of protective humoral and cellular immune responses (Gigliotti & Wright, 2012).